In the context of prostate tumor development and progression, we speculate that the epigenetic suppression of ATF3 by EZH2 by might be an important protective mechanism that promotes survival as tumors develop/progress and are subject to increasing cellular and environmental insults. Here, ATF3 is linked to prostate neoplasm.